Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance
Filings
68 filings of HSCL since January 2025; the newest 40 below.
acquisition 22, board outcome 19, presentation 10, transcript 7, credit rating 5, results 2
| Filed | Type | Subject | |
|---|---|---|---|
| 07 Nov 2026 | board outcome Acquisition, Legal | Himadri Speciality Chemical Limited has informed the Exchange regarding Outcome of Board Meeting held on November 07, 2026.AI summaryHimadri Speciality Chemical Ltd filed the outcome of its board meeting held on 07 November 2026, which ran from 10:15 a.m. to 10:45 a.m. (IST). The board approved a corporate guarantee of up to INR 200 Crores in favour of ICICI Bank Ltd to secure a credit facility of INR 200 Crores availed by Sturdy Niketan Private Limited, a step-down subsidiary. The company will charge guarantee commission on arm's length basis, and the guarantee will be disclosed as a contingent liability; promoter group has no interest in the transaction. The board approved shifting the corporate office to 5th Floor, C6/108/New, Budge Budge Trunk Road, Kolkata-700088, effective 07 November 2026; the old office at 8, India Exchange Place, Kolkata will remain as an additional place of office. The registered office is unchanged. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Oct 2026 | transcript Acquisition, Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about Transcript of Earnings Conference Call for Financial Performance for the 2nd Quarter and Half Year ended 30 September 2026 held on Thursday, 22 October 2026AI summaryHimadri Speciality Chemical filed the transcript of its Q2 FY27 and H1 FY27 earnings conference call held on 22 October 2026 (period ended 30 September 2026). Management (Anurag Choudhary, CMD and CEO) said H1 FY27 consolidated revenue exceeded INR 3,000 crores, EBITDA exceeded INR 600 crores and PAT crossed INR 450 crores. Standalone Q2 FY27 revenue from operations was INR 1,543 crores (Q2 FY26: INR 1,070 crores), EBITDA INR 308 crores (up 27% YoY) and PAT INR 240 crores (up 28% YoY). Management reiterated confidence in its previously guided target of INR 1,100 crores plus PAT by FY28. Proposed demerger of the Birla Tyres business from Dalmia Bharat Refractories into Himadri is subject to statutory, regulatory, creditor and shareholder approvals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Oct 2026 | presentation Acquisition, Capex, Results | Himadri Speciality Chemical Limited has informed the Exchange about Investor PresentationAI summaryHimadri Speciality Chemical filed its investor presentation on the financial results for the quarter and six months ended 30 September 2026. Consolidated Q2 FY27 revenue was Rs. 1,691 Cr, EBITDA Rs. 303 Cr and PAT Rs. 231 Cr, against Q2 FY26 figures of Rs. 1,071 Cr, Rs. 238 Cr and Rs. 176 Cr respectively. The board approved on 21 Sept 2026 a demerger, by transfer and vesting of the Tyre Business of DBRL into HSCL, with an appointed date of 1 Oct 2026, subject to statutory, regulatory, creditor and shareholder approvals. The presentation also covers investments: AUD 45 million funding secured from ARENA, completion of 100% acquisition of Advano (USA), and incorporation of a wholly owned subsidiary, Ardent Impex FZCO, in Dubai. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 Oct 2026 | board outcome | Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. | NSE copy |
| 21 Sep 2026 | scheme Acquisition, Legal | Himadri Speciality Chemical Limited has informed the Exchange about Scheme of Arrangement between Dalmia Bharat Refractories Limited ( Demerged Company ) and Himadri Speciality Chemical Ltd ( Resulting Company ) and their respective sharehoAI summaryHimadri Speciality Chemical Ltd's board approved, on 21 September 2026, a Scheme of Arrangement under Sections 230-232 of the Companies Act, 2013 with Dalmia Bharat Refractories Limited. The scheme provides for demerger of DBRL's Tyre Business into HSCL as a going concern, with an appointed date of 1 October 2026, and issue of HSCL new shares to eligible DBRL shareholders per the share entitlement ratio. The Tyre Business turnover was INR 149.31 crores as on 31 March 2026, which the filing states is 3.39% of HSCL's total turnover for the year ended 31 March 2026. The scheme is subject to approvals from stock exchanges, SEBI, NCLT, shareholders and creditors, and other authorities. The board's stated rationale is a more focused ownership and operating structure for the tyre business, and integration with HSCL's carbon black and advanced carbon materials business. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 Sep 2026 | board outcome Acquisition, Legal | Himadri Speciality Chemical Limited has informed the Exchange regarding Outcome of Board Meeting held on September 21, 2026 approving Scheme of Arrangement between Dalmia Bharat Refractories Limited ( Demerged Company ) and Himadri SpecialiAI summaryThe board of Himadri Speciality Chemical Ltd approved, at its meeting of 21 September 2026, a Scheme of Arrangement with Dalmia Bharat Refractories Limited under Sections 230-232 of the Companies Act, 2013. The Scheme provides for demerger of the Tyre Business of DBRL into HSCL as a going concern on an as-is-where-is basis, with HSCL issuing new shares to eligible DBRL shareholders per the share entitlement ratio. The appointed date is 1 October 2026, subject to NCLT and other approvals; turnover of the demerged undertaking for year ended 31 March 2026 was INR 149.31 crores, 3.39% of HSCL's total turnover. Management said the demerger would give the Tyre Business a more focused ownership and operating structure and allow integration with HSCL's carbon black and advanced carbon materials business. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 18 Sep 2026 | board outcome Legal | Himadri Speciality Chemical Limited has informed the Exchange that the Board of Directors ( Board ) at its meeting held today i.e., on 18 September 2026, inter-alia has considered and approved the alteration to the existing Memorandum of AsAI summaryBoard of Himadri Speciality Chemical Ltd approved, at its meeting on 18 September 2026, alterations to the Memorandum of Association by adding new sub-clauses to the objects to be pursued on incorporation (Clause III(A)) to enable new business activities. The Board also approved adopting a revised MOA aligned with Schedule I of the Companies Act, 2013, by merging existing Clause III(C) into III(B) and renumbering clauses, without affecting existing objects. The revised MOA also changes the liability and capital clauses to align with the Companies Act, 2013. The amendments are subject to approval of members by postal ballot and any regulatory or statutory approvals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Aug 2026 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about incorporation of foreign Wholly Owned Subsidiary in Dubai, UAEAI summaryHimadri Speciality Chemical Ltd intimated under Regulation 30 of the SEBI Listing Regulations that its wholly owned subsidiary ARDENT IMPEX FZCO has been incorporated in the Dubai Airport Free Zone, Dubai, UAE. The subsidiary has an authorised capital of AED 200,000 divided into 200 shares of AED 1,000 each, and the company will hold 100% shareholding, funded entirely in cash. Date of incorporation is 22 June 2026; the certificate of formation was received on 31 August 2026. The subsidiary's objective is industrial chemicals trading and petrochemicals trading in Dubai, UAE; it has not yet commenced business and has no turnover. The company states the subsidiary has become a related party of the company, with no other promoter or group interest in it. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 25 Aug 2026 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about Update on investment in Sicona Battery Technologies Pty LtdAI summaryHimadri Speciality Chemical Ltd intimated under Regulation 30 an update on its investment in Sicona Battery Technologies Pty Ltd. The company has invested AUD 1,67,53,000 in cash for 1,67,53,000 CCNs of face value AUD 1.00 each under earlier tranches. A final tranche of AUD 16,94,000 was remitted in cash for 16,94,000 CCNs of face value AUD 1.00 each. The company now cumulatively holds 1,84,47,000 CCNs in Sicona; it has not acquired additional voting rights or control at present, as the investment is in convertible notes. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 Jul 2026 | transcript Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about TranscriptAI summaryHimadri Speciality Chemical filed the transcript of its Q1 FY27 earnings conference call, held on 16 July 2026 for the quarter ended 30 June 2026. Management said consolidated revenue was INR 1,432 Crores (up 28% from INR 1,118 Crores a year ago), EBITDA INR 313 Crores at a 22% margin, and PAT INR 228 Crores at a 16% margin. Management said standalone revenue was INR 1,274 Crores, standalone EBITDA INR 301 Crores at a 24% margin, and standalone PAT INR 223 Crores at an 18% margin. Management announced an indigenous carbon nanotube (CNT) technology with a planned capex of about INR 70 Crores for a 200 MTPA facility targeted for commissioning in Q4 FY27, and a conversion of 6,000 MTPA of carbon black capacity to super speciality carbon black at a capex of INR 170 Crores. Management said its 200 MTPA anode material facility was commissioned in April 2026, and an initial 2,000 MTPA LFP cathode capacity is expected in Q3 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 Jul 2026 | presentation Capex, Results | Himadri Speciality Chemical Limited has informed the Exchange about Investor PresentationAI summaryHimadri Speciality Chemical filed an investor presentation on its financial results for the quarter ended 30 June 2026 (Q1FY27), stated to be available on the company website. Consolidated revenue for Q1FY27 was Rs. 1,432 Cr, up 28.04% YoY. Consolidated EBITDA was Rs. 313 Cr, up 33.10% YoY. Consolidated PAT was Rs. 228 Cr, up 27.36% YoY. The presentation describes India's first commercial carbon nano tube (CNT) plant, with capex of Rs. 70 Cr, capacity of 200 MTPA and a target of Q4FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 Jul 2026 | board outcome Capex, Results | Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryHimadri Speciality Chemical Ltd's board met on 15 July 2026 and approved the unaudited consolidated and standalone financial results for the quarter ended 30 June 2026; the limited review report from Singhi & Co is enclosed, but the figures are not in the pages provided. Board approved an additional capex of Rs 128 crore to raise Anthraquinone and Carbazole capacity from 2,600 MTPA to 5,300 MTPA, funded by internal accruals; Phase 1 (2,600 MTPA) due by Q2FY27 and Phase 2 (2,700 MTPA) by Q2FY28. Board approved capex of Rs 70 crore for a 200 MT per annum Carbon Nano Tubes facility in West Bengal using in-house technology, funded by internal accruals, expected to be commissioned by Q4FY27. Board approved capex of Rs 170 crore for a 6,000 MTPA Super Speciality Carbon Black facility at Mahistikry, funded primarily by internal accruals, expected to be commissioned by Q4FY28; total carbon black capacity stays at 250,000 MTPA. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Jul 2026 | credit rating Rating | Himadri Speciality Chemical Limited has informed the Exchange about Credit RatingAI summaryHimadri Speciality Chemical Ltd filed a rating disclosure under Regulation 30(2) of the SEBI LODR Regulations, 2015, dated 10 July 2026. ICRA Limited, by letter dated 10 July 2026, assigned [ICRA]AA (Stable) long-term and [ICRA]A1+ short-term ratings to fund-based/non-fund-based working capital facilities of Rs 1,980.86 crore. The long-term rating was upgraded from [ICRA]AA- (Positive), with outlook revised to Stable from Positive; the short-term rating was reaffirmed. ICRA reaffirmed the [ICRA]A1+ rating on commercial paper of Rs 500.00 crore. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 18 Jun 2026 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about AcquisitionAI summaryHimadri Speciality Chemical Ltd filed an update under Regulation 30 on its investment in International Battery Company, Inc. (IBC), a Delaware corporation. The company has made a further investment of USD 0.66 million for 6,00,000 common stock of IBC, completed on 18 June 2026, paid in cash. Aggregate stake in IBC after this investment is 20.47% on a fully diluted basis, up from 17.29%, with an aggregate cost of acquisition of USD 6.09 million. IBC's turnover for FY 2025 was nil as per its last audited financial statements; the acquisition is not a related party transaction and requires no governmental or regulatory approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 19 May 2026 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about update on investment in Sicona Battery Technologies Pty LtdAI summaryHimadri Speciality Chemical Ltd intimated under Regulation 30 an update on its investment in Sicona Battery Technologies Pty Ltd, made through compulsorily convertible notes (CCNs) of face value AUD 1.00 each. The company has further invested AUD 25,59,000 in cash for 25,59,000 CCNs in this update, taking its cumulative holding to 1,67,53,000 CCNs. The company has invested in CCNs in agreed tranches and will invest in the balance 16,94,000 CCNs in later tranches. The company has not acquired any additional voting rights or control in Sicona at present, as the investment is in CCN form. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | credit rating Rating | Himadri Speciality Chemical Limited has informed the Exchange about Credit RatingAI summaryHimadri Speciality Chemical Ltd filed intimation under Regulation 30 of SEBI Listing Regulations about an ESG rating action. ICRA ESG Ratings Limited, by letter dated 12 May 2026, revised the company's ESG rating from [ICRA ESG] Combined Rating 80, Exceptional to [ICRA ESG] Combined Rating 82, Exceptional. The company stated the rating reflects its efforts and performance across Environmental, Social and Governance pillars. The rating information will be made available on the company's website at www.himadri.com. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 May 2026 | transcript Acquisition, Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about TranscriptAI summaryHimadri Speciality Chemical filed the transcript of its Q4 and FY26 earnings conference call held on 27 April 2026. Management said the first anode material facility at Mahistikry, West Bengal, with initial capacity of 200 metric tons per annum, was commissioned on 23 April 2026, and that Phase 1 LFP cathode active material capacity of 2,000 metric tons is targeted for commissioning by Q3 FY27. Management reported consolidated FY26 revenue of about INR 4,661 crores, EBITDA of about INR 1,006 crores (up about 19% year-on-year) and PAT of INR 755 crores (up about 36% year-on-year). Management reported standalone FY26 revenue of INR 4,405 crores, EBITDA of about INR 978 crores and PAT of about INR 750 crores. Management said R&D spend in the year was INR 120 crores and that the Birla Tyres revival and the Sicona and IBC collaborations are progressing. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | presentation Capex, Dividend / buy-back, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about Investor PresentationAI summaryHimadri Speciality Chemical filed an investor presentation on its financial results for the quarter and year ended 31 March 2026. FY26 consolidated record EBITDA of Rs. 1,006 crore, record PBT of Rs. 1,001 crore and record PAT of Rs. 755 crore; FY26 revenue from operations was Rs. 4,660.7 crore. Q4FY26 revenue from operations was Rs. 1,288 crore, up about 14% from Q4FY25. Consolidated net cash position of Rs. 121 crore at year end. The Board recommended a final dividend of Re 0.80 per equity share of Re 1 each for FY2025-26, subject to shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | acquisition Acquisition, Capex, Dividend / buy-back, Management change, Results | Himadri Speciality Chemical Limited has informed the Exchange about incorporation of foreign Wholly Owned Subsidiary in ChinaAI summaryHimadri Speciality Chemical Ltd filed the outcome of its board meeting held on 23 April 2026, which approved audited standalone and consolidated financial results for the quarter and year ended 31 March 2026. The board recommended a final dividend of Re. 0.80 per equity share of Re. 1 each (80% of face value) for FY 2025-26, subject to shareholder approval. The board re-appointed Ernst & Young LLP as internal auditor and appointed Mr. Sambhu Banerjee as cost auditor for FY 2026-27. The board approved re-appointment of Independent Directors Girish Paman Vanvari (w.e.f. 22 June 2026) and Gopal Ajay Malpani (w.e.f. 13 August 2026) for second five-year terms, subject to shareholder approval. The board approved incorporating a foreign wholly owned step-down subsidiary in Guangzhou, China, subject to regulatory approvals if required. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | dividend Acquisition, Capex, Dividend / buy-back, Management change, Results | Himadri Speciality Chemical Limited has informed the Exchange that Board of Directors at its meeting held on April 23, 2026, recommended Final Dividend of Rs. 0.80 per equity share.AI summaryBoard meeting outcome filed on 23 April 2026 after audited standalone and consolidated results for quarter and year ended 31 March 2026 were approved. The Board recommended a final dividend of Re. 0.80 per equity share of Re. 1 each (80% of face value) for FY 2025-26, subject to shareholder approval. The Board re-appointed Ernst & Young LLP as Internal Auditor and appointed Mr. Sambhu Banerjee as Cost Auditor for FY 2026-27. The Board approved re-appointment of Independent Directors Girish Paman Vanvari (w.e.f. 22 June 2026) and Gopal Ajay Malpani (w.e.f. 13 August 2026) for second five-year terms, subject to shareholder approval. The Board approved incorporation of a foreign wholly owned step-down subsidiary in Guangzhou, China, subject to regulatory approvals if required. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | board outcome Acquisition, Capex, Dividend / buy-back, Management change, Results | Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryBoard of Himadri Speciality Chemical Ltd approved audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, along with statements of assets and liabilities and cash flows. The Board recommended a final dividend of Re. 0.80 per equity share of Re. 1 each (80% of face value) for FY 2025-26, subject to shareholder approval. The Board re-appointed Ernst & Young LLP as Internal Auditor and appointed Mr. Sambhu Banerjee as Cost Auditor, both for FY 2026-27. The Board approved re-appointment of Girish Paman Vanvari (w.e.f. 22 June 2026) and Gopal Ajay Malpani (w.e.f. 13 August 2026) as Independent Directors for a second five-year term, subject to shareholder approval. The Board approved incorporation of a foreign wholly owned step-down subsidiary in Guangzhou, China, subject to any required regulatory approvals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 20 Mar 2026 | credit rating Rating | Himadri Speciality Chemical Limited has informed the Exchange about Credit RatingAI summaryHimadri Speciality Chemical Ltd filed a rating disclosure under Regulation 30 of the SEBI LODR Regulations, 2015. India Ratings and Research Private Limited (Ind-Ra) affirmed the credit rating on the company's commercial paper, by letter dated 20 March 2026. The rated commercial paper amount is INR 100 crore, with the rating IND A1+ (Affirmed). The company states the information will also be available on its website, www.himadri.com. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Feb 2026 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about AcquisitionAI summaryHimadri Speciality Chemical Ltd has completed the acquisition of 100% paid-up equity share capital of Himadri Power Limited. Total purchase consideration is INR 2,50,000 (Indian Rupees Two Lakh Fifty Thousand only), paid in cash, by purchase of equity shares from the existing shareholder of the target company. Himadri Power Limited became a wholly owned subsidiary of the company with effect from 11 February 2026. Required disclosures under Regulation 30 were already provided in the company's letter dated 04 February 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 04 Feb 2026 | acquisition Acquisition, Legal | Himadri Speciality Chemical Limited has informed the Exchange about Acquisition of 100% paid-up equity share capital of Himadri Power LimitedAI summaryHimadri Speciality Chemical Ltd's board, at its meeting on 04 February 2026, approved the acquisition of 100% of the paid-up equity share capital of Himadri Power Limited for a total purchase consideration of INR 2,50,000 in cash. Himadri Power Limited had nil turnover in the financial year ended 31 March 2025 and paid-up capital of INR 5,00,000; it will become a wholly owned subsidiary on completion. The board also approved a share purchase agreement with the target company and its existing shareholders; the target is a related party, as its shareholders are the promoters and their relatives. The acquisition is expected to complete within 60 days of signing the SPA, and no governmental or regulatory approvals are stated as required. The stated objective is to enter the business of mining, development, operation, processing and refining of minerals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 04 Feb 2026 | board outcome Acquisition, Legal | Himadri Speciality Chemical Limited has informed the Exchange regarding Outcome of Board Meeting held on February 04, 2026.AI summaryHimadri Speciality Chemical Ltd's board, at its meeting on 04 February 2026, approved the acquisition of 100% paid-up equity share capital of Himadri Power Limited for a total purchase consideration of INR 2,50,000 in cash. The acquisition is to be made from existing shareholders under a share purchase agreement, and Himadri Power Limited will become a wholly owned subsidiary on completion. The acquisition is expected to be completed within 60 days from signing the SPA, or such date as mutually agreed. The target company is a related party, with promoters and their relatives holding 100% of its shares; the company states the transaction is at arm's length. The target had nil turnover for FY ended 31 March 2025; the stated objective is entry into mining, development, operation, processing and refining of minerals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2026 | transcript Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about TranscriptAI summaryTranscript of Q3 and 9M FY26 earnings conference call held on 21 January 2026 is filed under Regulation 30 of SEBI Listing Regulations. Management said standalone Q3 FY26 revenue was INR1,133 crores, EBITDA INR249 crores (up 12% YoY) and PAT INR195 crores (up 37% YoY); 9M FY26 standalone PAT was INR564 crores (up 41% YoY). Management said consolidated Q3 FY26 PAT was INR192 crores (up 36% YoY) and 9M FY26 consolidated PAT was about INR548 crores (up 37% YoY). Management said trial production has started at the speciality carbon black expansion project and the first commercial LFP cathode phase of 40,000 metric tons per annum remains on track for Q3 FY27. Management reiterated guidance that PAT will double from FY25 levels by FY28. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 Jan 2026 | presentation Capex, Results | Himadri Speciality Chemical Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation on financial results for the quarter ended 31 December 2025 (9MFY26), filed under Regulation 30 of SEBI LODR. On a standalone basis, 9MFY26 revenue was Rs. 3,304 crores (down 5% YoY from Rs. 3,467 crores), EBITDA Rs. 726 crores (up 19% from Rs. 611 crores) and PAT Rs. 564 crores (up 41% from Rs. 400 crores). Sales volume was 4,28,572 MT in 9MFY26, about 3% higher YoY; EBITDA per MT rose 15% to Rs. 16,934. Management said it is expanding speciality carbon black capacity by a brownfield 70,000 MTPA line, taking the total to 1,30,000 MTPA, at an estimated capex of Rs. 220 crores; trial production started in December 2025. Management reported the first export shipment of liquid coal tar pitch (3,600 tons) delivered in November 2025 to the Middle East from Mangalore Port. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 Jan 2026 | board outcome Results | Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryHimadri Speciality Chemical Ltd filed the outcome of its board meeting held on 16 January 2026, approving unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. Standalone revenue from operations for the quarter ended 31.12.2025 was Rs 1,132.97 crore, against Rs 1,131.81 crore in the corresponding quarter of the previous year. Standalone net profit after tax for the quarter ended 31.12.2025 was Rs 194.58 crore, against Rs 141.94 crore in the corresponding quarter of the previous year. Standalone nine-month revenue from operations was Rs 3,303.80 crore, and nine-month net profit after tax was Rs 564.00 crore. Statutory auditor Singhi & Co issued a limited review report with no reported misstatements. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 14 Jan 2026 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about Update on investment in Sicona Battery Technologies Pty LtdAI summaryHimadri Speciality Chemical Ltd intimated under Regulation 30 of SEBI Listing Regulations an update on its investment in Sicona Battery Technologies Pty Ltd. The company invested a further AUD 37,03,000 in cash for 37,03,000 Compulsorily Convertible Notes (CCNs) of face value AUD 1.00 each, following earlier investment of AUD 1,04,91,000. The company now cumulatively holds 1,41,94,000 CCNs in Sicona; investment in the balance 42,53,000 CCNs will be made in agreed tranches. The company has not acquired additional voting rights or control in Sicona at present, as the investment is in CCN form convertible into shares per agreed terms. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Oct 2025 | transcript Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about TranscriptAI summaryHimadri Speciality Chemical filed the transcript of its Q2 and H1 FY26 earnings conference call held on 24 October 2025. Management said Q2 FY26 standalone EBITDA was Rs. 243 crores (up 21% year-on-year) and PAT was Rs. 187 crores (up 39%), both the highest ever quarterly levels; H1 standalone EBITDA was Rs. 477 crores and PAT Rs. 369 crores. Standalone Q2 FY26 revenue from operations was Rs. 1,070 crores versus Rs. 1,135 crores in Q2 FY25, which management attributed to lower raw material prices, a focus on high value-added products and export sales recognition deferred to Q3. Management said the speciality carbon black expansion to 130,000 MT per annum is due by end of Q3 FY26, and the coal tar pitch distillation capacity is rising from 500,000 MT to 600,000 MT, with volume growth expected from Q4. Management said it is already nearing its target of doubling FY24 PAT of Rs. 411 crores by FY27 and expects FY27 to far exceed original expectations. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Oct 2025 | presentation Results | Himadri Speciality Chemical Limited has informed the Exchange about Investor PresentationAI summaryHimadri Speciality Chemical filed an investor presentation on its financial results for the quarter ended 30 September 2025, with the cover letter dated 17 October 2025. Standalone quarterly figures shown: EBITDA of Rs. 232 Cr (Q2 FY26) and PAT of Rs. 158 Cr; the presentation describes these as the highest ever quarterly EBITDA and PAT. H1 FY26 standalone: EBITDA Rs. 477 Cr (up 23% vs H2 FY25 per the slide's comparison), PAT Rs. 369 Cr (up 43%), revenue Rs. 2,171 Cr (down 7%), sales volume 2,75,603 MT (down 1%). Management attributes the revenue decline to lower raw material prices and notes an export order executed in the quarter whose revenue will be recognised in the next quarter. Management states the product mix remains focused on high value-added products. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Oct 2025 | board outcome Results | Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.AI summaryHimadri Speciality Chemical Ltd's board, at its meeting on 17 October 2025, approved the unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2025. Standalone revenue from operations for the quarter ended 30 September 2025 was Rs 1,070.41 crore, against Rs 1,100.42 crore in the previous quarter and Rs 1,135.21 crore in the corresponding quarter last year. Standalone net profit after tax for the quarter ended 30 September 2025 was Rs 186.85 crore, against Rs 182.57 crore in the previous quarter and Rs 134.44 crore in the corresponding quarter last year. Standalone basic earnings per share for the quarter was Rs 3.78. Statutory auditor Singhi & Co issued an unmodified limited review report on the standalone results. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 12 Sep 2025 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about update on investment in Sicona Battery Technologies Pty LtdAI summaryHimadri Speciality Chemical Ltd filed an intimation under Regulation 30 of the SEBI Listing Regulations on an update to its investment in Sicona Battery Technologies Pty Ltd. The company has further invested AUD 15,00,000 in cash for 15,00,000 Compulsorily Convertible Notes (face value AUD 1.00 each) in Sicona. Earlier, the Board approved a further investment of AUD 1,50,00,000 through CCNs in agreed tranches over 18 months; AUD 41,71,000 was invested before this tranche, leaving 1,08,29,000 CCNs to be subscribed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Sep 2025 | credit rating Rating | Himadri Speciality Chemical Limited has informed the Exchange about Credit RatingAI summaryHimadri Speciality Chemical Ltd filed an intimation under Regulation 30(2) of the SEBI LODR Regulations about a credit rating letter from ICRA Limited dated 10 September 2025. ICRA assigned [ICRA]AA- (Positive)/[ICRA]A1+ with Positive outlook to fund based/non-fund based working capital facilities of Rs 1,980.86 crore, reaffirmed or assigned for enhanced amount. ICRA reaffirmed [ICRA]A1+ on Rs 300.00 crore commercial paper and assigned [ICRA]A1+ to Rs 200.00 crore commercial paper. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Jul 2025 | transcript Acquisition, Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about TranscriptAI summaryHimadri Speciality Chemical filed the transcript of its Q1 FY26 earnings conference call held on 18 July 2025 (quarter ended 30 June 2025). Management said standalone EBITDA was Rs. 234 crores (up 25% from Rs. 188 crores) and standalone PAT was Rs. 183 crores (up 48% from Rs. 123 crores); consolidated revenue was Rs. 1,118 crores versus Rs. 1,200 crores a year ago, impacted by lower raw material prices. Management said net debt was Rs. 107 crores and ROCE was 32% (excluding investments and capital work in progress) as of 30 June 2025. Management said speciality carbon black capacity expansion of 70,000 tonnes per annum is on track for commissioning by Q3 FY26, and the LFP cathode plant is expected to be operational by Q3 FY27. Management said anode CAPEX will be announced once engineering is complete, and that volume growth is expected from Q3-Q4 as capacity comes on stream. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 Jul 2025 | presentation Acquisition, Capex, Guidance, Results | Himadri Speciality Chemical Limited has informed the Exchange about Investor PresentationAI summaryHimadri Speciality Chemical Ltd filed an investor presentation on its financial results for the quarter ended 30 June 2025, under Regulation 30 of the SEBI LODR Regulations. The presentation sets a roadmap to FY2028, including Speciality Carbon Black expansion to be completed by Q3FY26, Birla Tyres commencement in Q1FY26, and a Phase 1 LFP Cathode Active Material commercial plant to be operational in Q3FY27. Capex figures shown are Rs. 306 Cr, Rs. 1,125 Cr and Rs. 220 Cr, with Rs. 120 Cr noted for Birla Tyres additional capex over the next 3 years, funded through internal accruals. Investments disclosed include Rs. 84.21 Cr for a ~15% post-conversion stake in Sicona Battery Technologies, Rs. 45.16 Cr for a 40% stake in Invati Creations, and USD 4.43 Mn (approx. Rs. 37.47 Cr) for a 16.24% stake in International Battery Company, Inc., USA. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 Jul 2025 | board outcome Acquisition, Management change | Himadri Speciality Chemical Limited has informed the Exchange regarding Outcome of Board Meeting held on July 15, 2025.AI summaryBoard of Himadri Speciality Chemical Ltd approved incorporation of a foreign wholly owned subsidiary in Dubai, UAE, to be named "Alliance Worldwide LLC" (or other name approved by host-country authority), to expand overseas business. The Board designated Mr. Soumyodeep Bhattacharya, Executive Vice President (CTD), an existing employee, as Key Managerial Personnel under Section 2(51) of the Companies Act, 2013 and as Senior Management Personnel under Regulation 16(1)(d) of SEBI Listing Regulations. The company stated it will disseminate further disclosures on the subsidiary upon incorporation. The board meeting was held on 15 July 2025, from 12:00 p.m. to 2:05 p.m. (IST). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 Jul 2025 | board outcome Results | Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.AI summaryBoard of Himadri Speciality Chemical Ltd approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 at a meeting held on 15 July 2025; statutory auditor Singhi & Co issued a limited review report. Standalone revenue from operations for Q1 FY26 was Rs. 1,100.42 crore, against Rs. 1,199.77 crore in the corresponding quarter last year. Standalone net profit after tax was Rs. 182.57 crore, against Rs. 123.45 crore in the corresponding quarter last year. Standalone basic EPS was Rs. 3.70 (Re. 1 face value), against Rs. 2.50 in the corresponding quarter last year. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jun 2025 | acquisition Acquisition | Himadri Speciality Chemical Limited has informed the Exchange about Update on investment for acquisition of 16.24% stake in International Battery Company, Inc.AI summaryHimadri Speciality Chemical Ltd intimated under Regulation 30 of the SEBI Listing Regulations that it has paid the total purchase consideration of USD 4.43 Million in cash for a 16.24% stake in International Battery Company, Inc. (fully diluted basis). The payment covers purchase of 600,000 common stock from an existing shareholder, subscription of 2,100,000 common stock, and subscription of 379,175 Series A Preferred Stock. This update follows the earlier announcement dated 22 May 2025, when the Board approved the acquisition. Information required under Schedule III was already provided to the exchanges via letter dated 22/05/2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 May 2025 | acquisition Acquisition, Capex | Himadri Speciality Chemical Limited has informed the Exchange about Acquisition of 16.24% stake of International Battery Company, Inc.AI summaryHimadri Speciality Chemical Ltd's board approved on 22 May 2025 the acquisition of a 16.24% stake in International Battery Company, Inc. (IBC), a Delaware corporation, on a fully diluted basis. The stake comprises purchase of 600,000 common stock from an existing shareholder, subscription of 2,100,000 common stock, and subscription of 379,175 Series A Preferred Stock. Total purchase consideration is USD 4.43 Million (approximately INR 37.47 Crores), paid in cash, with completion expected within 30 days of execution of each transaction document. The company stated the deal is a significant milestone for commercial deployment of its LFP cathode active and anode materials, and gives access to IBC's manufacturing infrastructure in South Korea and its upcoming Gigafactory in Bengaluru. The acquisition is not a related party transaction and requires no governmental or regulatory approval, per the filing. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.